相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD279 (PD-1)
- 级别:
CD279 (PD-1) Antibody
- 目录编号:
CD279 (PD-1) Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
CD279 (PD-1) Antibody
- 抗体英文名:
anti-mouse CD279 (PD-1) Antibody-FITC
- 抗体名:
CD279 (PD-1) Antibody
- 标记物:
FITC
- 宿主:
大鼠
- 适应物种:
小鼠
- 免疫原:
CD279 (PD-1) Antibody
- 亚型:
CD279 (PD-1) Antibody
- 形态:
CD279 (PD-1) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
0.5 mg/ml
- 规格:
50 µg/200 µg
| 规格: | 50 µg | 产品价格: | ¥1800.0 |
|---|---|---|---|
| 规格: | 200 µg | 产品价格: | ¥5400.0 |
anti-mouse CD279 (PD-1) Antibody-FITC详细如下:
Description :CD279, also known as programmed death-1 (PD-1), is a 50-55 kD glycoprotein belonging tothe CD28 family of the Ig superfamily. PD-1 is expressed on activated splenic T and B cells andthymocytes. It is induced on activated myeloid cells as well. PD-1 is involved in lymphocyteclonal selection and peripheral tolerance through binding its ligands, B7-H1 (PD-L1) and B7-DC (PD-L2). It has been reported that PD-1 and PD-L1 interactions are critical to positiveselection and play a role in shaping the T cell repertoire. PD-L1 negative costimulation isessential for prolonged survival of intratesticular islet allografts.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Immunogen :PD-1 cDNA followed by PD-1-Ig fusion protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography, and conjugated with FITC under optimalconditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Excitation Laser :Blue Laser (488 nm)
Description :CD279, also known as programmed death-1 (PD-1), is a 50-55 kD glycoprotein belonging tothe CD28 family of the Ig superfamily. PD-1 is expressed on activated splenic T and B cells andthymocytes. It is induced on activated myeloid cells as well. PD-1 is involved in lymphocyteclonal selection and peripheral tolerance through binding its ligands, B7-H1 (PD-L1) and B7-DC (PD-L2). It has been reported that PD-1 and PD-L1 interactions are critical to positiveselection and play a role in shaping the T cell repertoire. PD-L1 negative costimulation isessential for prolonged survival of intratesticular islet allografts.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Immunogen :PD-1 cDNA followed by PD-1-Ig fusion protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation :The antibody was purified by affinity chromatography, and conjugated with FITC under optimalconditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Excitation Laser :Blue Laser (488 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Good-Jacobson KL, et al. 2010. Nat. Immunol. 11:535. (FC) PubMed
2. Lázár-Molnár E, et al. 2008. Proc. Natl. Acad. Sci. USA 105:2658. (Block)
3. Liang SC, et al. 2003. Eur. J. Immunol. 33:2706. (FC, IHC, Block)
4. Tobias J, et al. 2020. Front Immunol. 11:895 (FC, ELISA) PubMed
5. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
6. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations:
1. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
2. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
3. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
4. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
5. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
6. Gengenbacher M, et al. 2016. MBio. 7: 00679-16. PubMed
7. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
8. Weigelin B, et al. 2015. Proc Natl Acad Sci U S A. 112:7551. PubMed
9. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
10. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
11. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
12. Etxeberria I, et al. 2020. Cancer Cell. 36(6):613-629. PubMed
1. Good-Jacobson KL, et al. 2010. Nat. Immunol. 11:535. (FC) PubMed
2. Lázár-Molnár E, et al. 2008. Proc. Natl. Acad. Sci. USA 105:2658. (Block)
3. Liang SC, et al. 2003. Eur. J. Immunol. 33:2706. (FC, IHC, Block)
4. Tobias J, et al. 2020. Front Immunol. 11:895 (FC, ELISA) PubMed
5. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
6. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations:
1. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
2. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
3. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
4. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
5. Ghosh S, et al. 2022. APL Bioeng. 6:036105. PubMed
6. Gengenbacher M, et al. 2016. MBio. 7: 00679-16. PubMed
7. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
8. Weigelin B, et al. 2015. Proc Natl Acad Sci U S A. 112:7551. PubMed
9. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
10. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
11. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
12. Etxeberria I, et al. 2020. Cancer Cell. 36(6):613-629. PubMed
文献支持
抗小鼠 CD279 (PD-1) 荧光标记FITC 抗体
¥1800 - 5400










